rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
6
|
pubmed:dateCreated |
2005-11-24
|
pubmed:abstractText |
Human mesenchymal stem cells (hMSC) have been isolated and characterized extensively for a variety of clinical applications. Yet it is unclear how the phenomenon of hMSC plasticity can be safely and reasonably exploited for therapeutic use.
|
pubmed:grant |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:issn |
1465-3249
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
7
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
509-19
|
pubmed:dateRevised |
2008-4-24
|
pubmed:meshHeading |
pubmed-meshheading:16306013-Aneuploidy,
pubmed-meshheading:16306013-Animals,
pubmed-meshheading:16306013-Antigens, CD,
pubmed-meshheading:16306013-Bone Marrow Cells,
pubmed-meshheading:16306013-Cell Line, Transformed,
pubmed-meshheading:16306013-Glycoproteins,
pubmed-meshheading:16306013-Humans,
pubmed-meshheading:16306013-Immunophenotyping,
pubmed-meshheading:16306013-Karyotyping,
pubmed-meshheading:16306013-Mesenchymal Stem Cell Transplantation,
pubmed-meshheading:16306013-Mesenchymal Stem Cells,
pubmed-meshheading:16306013-Mice,
pubmed-meshheading:16306013-Mice, Inbred NOD,
pubmed-meshheading:16306013-Mice, SCID,
pubmed-meshheading:16306013-Neoplasms, Experimental,
pubmed-meshheading:16306013-Neoplastic Stem Cells,
pubmed-meshheading:16306013-Peptides,
pubmed-meshheading:16306013-Time Factors
|
pubmed:year |
2005
|
pubmed:articleTitle |
Outgrowth of a transformed cell population derived from normal human BM mesenchymal stem cell culture.
|
pubmed:affiliation |
Division of Hematologic Malignancies, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland 21231, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, N.I.H., Extramural
|